We are a bioincubator helping emerging biotechs decreasing their time to seed funding.

We have a growing commitment to engineering innovation that improves industrial efficiency.

latest news older news

ULB researchers have identified tumor cell populations responsible for metastasis

In a study published in Nature, research team led by Prof. Cédric Blanpain, MD/PhD, WELBIO investigator and Professor at the Université libre de Bruxelles, Belgium, identified for the first time, the different tumor transition states occurring during cancer progression and identified subpopulations of tumor cells responsible for metastasis in skin squamous cell carcinoma, the second most frequent cancer worldwide, and breast cancer, the most frequent cancers in women. Please find the official press release of ULB here

Read more

Spectralys Biotech is looking for a Business Developer

Spectralys Biotech, an in-creation ULB spin-off offering innovative analytical solutions for biomolecules based on infrared spectroscopy (FTIR), is looking for a Business Developer to promote adoption of its technology in the biopharmaceutical industry. Interested? Please find the job offering and contact details here

Read more
Learn more about our events all events next event

MedTech Booster

Market opportunity validation

This one day booster aims at advising early stage MedTech projects on how to conduct a professional market validation...

Read more